上海医药集团股份有限公司等嘧啶环类化合物、其中间体、其药物组合物及其应用专利完成登记(医药化学专利快讯)

DoNews
Oct 14, 2025

天眼查App显示,2025-10-14,“嘧啶环类化合物、其中间体、其药物组合物及其应用”正式进入专利的公布阶段。申请人为上海医药集团股份有限公司,该项医药化学专利涉及KRAS突变体抑制及蛋白降解治疗技术领域。据专利信息显示,该化合物对KRAS突变体具有良好的抑制作用或蛋白降解作用,有望在肿瘤靶向治疗中实现突破性进展。发明人为李迪;段灵峻;浦小青;楼江松;霍国永;马星;夏广新。本发明公开了一种嘧啶...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10